Zimmer Biomet Holdings Stock News

Zimmer Biomet (ZBH) gets FDA nod for the Identity Shoulder System to help surgeons perform anatomic, reverse and revision shoulder replacement with precision.

Zimmer (ZBH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zimmer Biomet's (ZBH) recently completed spin-off of the non-core dental and spine business is expected to prove strategic.

Zimmer Biomet's (ZBH) HipInsight is a mixed reality-based visualization tool that will aid surgeons in precise implant placement and alignment during total hip replacement.

The stocks of these high-quality companies are compelling today. 0:00 Introduction 0:50 Equifax EFX 1:14 Salesforce CRM 1:43 Zimmer Biomet ZBH Learn more about these stocks.

The competitive advantage of Zimmer Biomet as a leader in the industry it operates in which shielded the company from the recent pandemic headwinds. High switching costs are its key competitive advant

Despite the COVID-induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ZBH, BIO, LNTH and HAE are well-poised

ZBH vs. LMAT: Which Stock Is the Better Value Option?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Keri Mattox - Senior Vice President, Chief Communications and Administration Of

The contraction in Zimmer Biomet's (ZBH) gross margin is concerning.

You're tempted to increase exposure to stocks because of the market's strength. But you're still gun shy because of the painful selloff.

Zimmer (ZBH) delivered earnings and revenue surprises of 11.66% and 3.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

While Johnson & Johnson's ( JNJ , Financial) Medtech sales were lower in the second quarter, revenue from hips and knee replacements was on target or above, a development that could spill over into se

Spinoffs are known for being a mixed bag from the investor's viewpoint. Some of them can unlock the true value of businesses by allowing them to focus on their niches rather than being hampered by und

Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The top 3 positions are T-Mobile US, Amazon.com, and General Electric, together, at ~16% of the portfolio.